The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

The Trump administration is decreasing funding for the development of mRNA (messenger RNA) vaccines, which were crucial in the response to COVID-19. Why it matters: mRNA vaccines are a public health ...

Some viruses mutate more rapidly than others. Learn more about why that is and what that means for your health.

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America: San Diego, California Monday, Decembe ...

Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa, according to Cairo, Egypt-headquartered drug firm Eva Pharma. Eva Pharma made ...

Messenger RNA vaccines aren’t just saving human lives—they are protecting elephants as well. In 2024, Tess, an elephant at the Houston Zoo, became the first to receive an mRNA vaccine developed by ...

The mRNA technology that helped end the COVID-19 pandemic may now hold the key to defeating cancer, and it exists because of ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

Covid-19 vaccines did not lead to higher death rates in France, according to a new study using data from 30 million adults.